# Chao-Qing Wu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chao-qing-wu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 494 |
| Field | Hormonal Regulation and Hypertension |
| h-index | 8 |
| i10-index | 7 |
| Last Known Institution | The People's Hospital of Guangxi Zhuang Autonomous Region |
| OpenAlex ID | https://openalex.org/A5058172891 |
| Works | 19 |

## Researcher papers

- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes](https://scholariq.org/papers/impact-of-finerenone-induced-albuminuria-reduction-on-chronic-kidney-disease/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-according/)
- [Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases](https://scholariq.org/papers/focal-segmental-glomerulosclerosis-excluding-atypical-lesion-is-a-predictor-of/)
- [Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-the/)
- [Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study](https://scholariq.org/papers/safety-and-effectiveness-of-hsk21542-for-hemodialysis-patients-a-multiple/)
- [Fine tuning of the coordination environments and magnetic properties of first row transition metal ions with 5-methylisophthalate and 2,2′-bipyridine/phenanthroline](https://scholariq.org/papers/fine-tuning-of-the-coordination-environments-and-magnetic-properties-of-first/)
- [Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-hsk21542-for-pruritus-management-in-hemodialysis-patients/)
- [Effect of Finerenone on CKD Outcomes in Type 2 Diabetes: A Chinese Subgroup Analysis of the FIDELIO-DKD Study](https://scholariq.org/papers/effect-of-finerenone-on-ckd-outcomes-in-type-2-diabetes-a-chinese-subgroup/)
- [Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis](https://scholariq.org/papers/finerenone-in-chinese-patients-with-chronic-kidney-disease-and-type-2-diabetes-a/)

## Researcher topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [The People's Hospital of Guangxi Zhuang Autonomous Region](https://scholariq.org/institutions/the-people-s-hospital-of-guangxi-zhuang-autonomous-region/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.